Partial spreads and vector space partitions

Constant-dimension codes with the maximum possible minimum distance have been studied under the name of partial spreads in Finite Geometry for several decades. Not surprisingly, for this subclass typically the sharpest bounds on the maximal code size are known. The seminal works of Beutelspacher and Drake \& Freeman on partial spreads date back to 1975, and 1979, respectively. From then until recently, there was almost no progress besides some computer-based constructions and classifications. It turns out that vector space partitions provide the appropriate theoretical framework and can be used to improve the long-standing bounds in quite a few cases. Here, we provide a historic account on partial spreads and an interpretation of the classical results from a modern perspective. To this end, we introduce all required methods from the theory of vector space partitions and Finite Geometry in a tutorial style. We guide the reader to the current frontiers of research in that field, including a detailed description of the recent improvements.Comment: 30 pages, 1 tabl

A global research priority agenda to advance public health responses to fatty liver disease

Background & aims An estimated 38% of adults worldwide have non-alcoholic fatty liver disease (NAFLD). From individual impacts to widespread public health and economic consequences, the implications of this disease are profound. This study aimed to develop an aligned, prioritised fatty liver disease research agenda for the global health community. Methods Nine co-chairs drafted initial research priorities, subsequently reviewed by 40 core authors and debated during a three-day in-person meeting. Following a Delphi methodology, over two rounds, a large panel (R1 n = 344, R2 n = 288) reviewed the priorities, via Qualtrics XM, indicating agreement using a four-point Likert-scale and providing written feedback. The core group revised the draft priorities between rounds. In R2, panellists also ranked the priorities within six domains: epidemiology, models of care, treatment and care, education and awareness, patient and community perspectives, and leadership and public health policy. Results The consensus-built fatty liver disease research agenda encompasses 28 priorities. The mean percentage of ‘agree’ responses increased from 78.3 in R1 to 81.1 in R2. Five priorities received unanimous combined agreement (‘agree’ + ‘somewhat agree’); the remaining 23 priorities had >90% combined agreement. While all but one of the priorities exhibited at least a super-majority of agreement (>66.7% ‘agree’), 13 priorities had 90% combined agreement. Conclusions Adopting this multidisciplinary consensus-built research priorities agenda can deliver a step-change in addressing fatty liver disease, mitigating against its individual and societal harms and proactively altering its natural history through prevention, identification, treatment, and care. This agenda should catalyse the global health community’s efforts to advance and accelerate responses to this widespread and fast-growing public health threat. Impact and implications An estimated 38% of adults and 13% of children and adolescents worldwide have fatty liver disease, making it the most prevalent liver disease in history. Despite substantial scientific progress in the past three decades, the burden continues to grow, with an urgent need to advance understanding of how to prevent, manage, and treat the disease. Through a global consensus process, a multidisciplinary group agreed on 28 research priorities covering a broad range of themes, from disease burden, treatment, and health system responses to awareness and policy. The findings have relevance for clinical and non-clinical researchers as well as funders working on fatty liver disease and non-communicable diseases more broadly, setting out a prioritised, ranked research agenda for turning the tide on this fast-growing public health threat

Publisher: Institute for Animal Husbandry, Belgrade-Zemun UDC 637.146.3 TECHNOLOGY AND CHEMICAL COMPOSITION OF BEATEN CHEESE IN REPUBLIC OF MACEDONIA**

Abstract: Beaten cheese is autochthonous product of our country whose production started long time ago. In the past it was produced only in the region Mariovo where it was made from pure sheep milk, but today it is produced in other regions of the country and from mix of sheep and cow milk and mix from sheep and goat milk. In the most parts of the country beaten cheese is manufactured in industrial conditions, but in some places it is still made at home. According to our research using two different types of renet, Chy-max (genetic rennet) and Stabbo (combined rennet) we developed technology for production of two variants of beaten cheese by industrial way. Chemical composition of beaten cheese produced by genetic rennet on 45 th day of the ripening was: dry matter 59.67%, fat 21.74%, proteins 21.95%, salt 3.58%, acidity 191 o T and pH 5.24. Beaten cheese made using combined rennet showed this chemical composition: dry matter 58.01%, fat 21.54%, proteins 22.09, salt 3.51%, acidity 184 o T and pH 5.17. The level of protein hydrolyses was in the type produced with combined rennet. Soluble nitrogen at the end of ripening was 0.66%, primary nitrogen materials 0.60 % and secondary nitrogen materials 0.05%. On 45 th day of ripening in brine quantity of soluble nitrogen in beaten cheese made with genetic rennet was 0.62%, primary nitrogen materials 0.57 % and secondary nitrogen materials 0.05%. The kinetics of salt diffusion was nearly equal and to the end of ripening in the first variant it was 3.5 % and in the second 3.51%. Because the level of dry matter used in first type was higher, cheese yield was 10.96%, compared to the second type where cheese yield was 8.63%

Doppler Parameters of Hepatic and Renal Hemodynamics in Patients with Liver Cirrhosis

Introduction. There are limited studies on simultaneous evaluation of liver and renal blood flow using Doppler methods. We evaluated and compared the changes of liver and renal Doppler US parameters in patients with liver cirrhosis according to the degree of liver disease. Material and Methods. We assessed a large spectrum of liver and renal Doppler US parameters in 67 patients with liver cirrhosis. Results. Significant differences between Child’s classes or score, as well as MELD score, were observed in all investigated intrarenal blood flow Doppler US parameters, except renal artery peak systolic velocity, but only in some of the hepatic ones. The deviations of renal Doppler US parameters were also related with the complications of liver cirrhosis, as well as serum urea and creatinine levels. There was relationship between Doppler US parameters of hepatic artery and the corresponding renal artery Doppler US parameters. The changes of Doppler US parameters were age independent. Conclusion. Our results show, renal Doppler US parameters correlate with the severity and complications of liver cirrhosis. Because of dynamic deviations of renal Doppler US parameters with advance of liver cirrhosis, we recommend Doppler US of renal artery as a part of follow up of these patients

YKL-40 and cytokines - a New Diagnostic Constellation in Rheumatoid Arthritis?

Background: Rheumatoid arthritis (RA) causes chronic inflammation and alteration of articular tissue and joints. The pathogenesis of the disease remains unclear although it is known that proinflammatory cytokines play a major role in its induction

Historical epidemiology of hepatitis C virus in select countries-volume 4

Due to the introduction of newer, more efficacious treatment options, there is a pressing need for policy makers and public health officials to develop or adapt national hepatitis C virus (HCV) control strategies to the changing epidemiological landscape. To do so, detailed, country-specific data are needed to characterize the burden of chronic HCV infection. In this study of 17 countries, a literature review of published and unpublished data on HCV prevalence, viraemia, genotype, age and gender distribution, liver transplants and diagnosis and treatment rates was conducted, and inputs were validated by expert consensus in each country. Viraemic prevalence in this study ranged from 0.2% in Hong Kong to 2.4% in Taiwan, while the largest viraemic populations were in Nigeria (2 597 000 cases) and Taiwan (569 000 cases). Diagnosis, treatment and liver transplant rates varied widely across the countries included in this analysis, as did the availability of reliable data. Addressing data gaps will be critical for the development of future strategies to manage and minimize the disease burden of hepatitis

Advancing the global public health agenda for NAFLD: a consensus statement.

Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects approximately one-quarter of the global adult population, causing a substantial burden of ill health with wide-ranging social and economic implications. It is a multisystem disease and is considered the hepatic component of metabolic syndrome. Unlike other highly prevalent conditions, NAFLD has received little attention from the global public health community. Health system and public health responses to NAFLD have been weak and fragmented, and, despite its pervasiveness, NAFLD is largely unknown outside hepatology and gastroenterology. There is only a nascent global public health movement addressing NAFLD, and the disease is absent from nearly all national and international strategies and policies for non-communicable diseases, including obesity. In this global Delphi study, a multidisciplinary group of experts developed consensus statements and recommendations, which a larger group of collaborators reviewed over three rounds until consensus was achieved. The resulting consensus statements and recommendations address a broad range of topics - from epidemiology, awareness, care and treatment to public health policies and leadership - that have general relevance for policy-makers, health-care practitioners, civil society groups, research institutions and affected populations. These recommendations should provide a strong foundation for a comprehensive public health response to NAFLD